Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Hereditary Hemorrhagic Telangiectasia Impact Genetics Dynacare/LabCorp Canada | 5 | 3 |
|
High-Resolution Rapid Microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Rapid microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
ACVRL1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 99 | 101 |
|
Centogene AG - the Rare Disease Company Germany | 110 | 112 |
|
Centogene AG - the Rare Disease Company Germany | 289 | 275 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Hereditary Hemorrhagic telangiectasia NGS panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 5 |
|
Hereditary Hemorrhagic telangiectasia Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 5 |
|
Hereditary Hemorrhagic telangiectasia Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 5 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Pulmonary Arterial Hypertension (PAH) Panel PreventionGenetics, part of Exact Sciences United States | 10 | 11 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 409 | 164 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 208 | 81 |
|
Invitae 78 Gene Actionable Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 220 | 75 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 171 | 137 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.